The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Can China Escape Its Demographic Bind?
Paul French discusses the effect of China's one-child policy on healthcare spending, pensions and social welfare.
Senhwa Biosciences Raises US$17m For Cancer Clinical Trials
Senhwa Biosciences has raised an additional US$17 million in Series B financing to drive its anticancer agents through critical clinical trials.
Ear Acupuncture Could Help People Lose Weight, Study
Acupuncture of five points on the outer ear - shen-men (divine gate), spleen, stomach, hunger and endocrine - can help shed the pounds, says a South Korean study.
ScinoPharm To Open Manufacturing Plant In Changshu, China
ScinoPharm has completed construction of its Changshu plant on a 16-acre site in China.
Cat & Dog Allergens Detected In Homes Without Pets
Soft toys are a source of cat and dog allergens regardless of whether the home has pets, according to a study.
Salmonella Disables Bacteria-Fighting Mast Cells During Invasion
A protein in Salmonella inactivates mast cells, rendering them unable to protect against bacterial invaders, according to a new study.
Mind-Body Exercises Benefit Emotional Health: Hong Kong Study
Mind-body exercises such as Tai Chi, Chi Gong and Yoga not only improve physical fitness but also alleviate mood disorders such as anxiety and depression, according to a study.
Migrating Skin Cells Form ‘Bridges’ During Wound Healing, Study
Researchers have discovered that outer skin cells are able to unite to form suspended “bridges” during wound healing.
Sox4 Oncogene Potential Target In Acute Myeloid Leukemia
The Sox4 oncogene may be a potential therapeutic target in the treatment of acute myeloid leukemia.